An fMRI study of the influence of a history of substance abuse on working memory-related brain activation in schizophrenia

Frontiers in Psychiatry

Volumn 5, Issue JAN, 2014, Pages

  Wojtalik, Jessica A ^a   Barch, Deanna M ^a,b,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

FMRI; N back; Neurocognition; Schizophrenia; Substance abuse; Working memory

Indexed keywords

EID: 84893438504     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2014.00001     Document Type: Article

References (74)

1. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug use: results from the epidemiologic catchment area (ECA) study. JAMA (1990) 264:2511-8. doi: 10.1001/jama.1990.03450190043026.
2. Potvin S, Joyal CC, Pelletier J, Stip E. Contradictory cognitive capacities among substance-abusing patients with schizophrenia: a meta-analysis. Schizophr Res (2008) 100:242-51. doi:10.1016/j.schres.2007.04.022.
3. Potvin S, Stavro K, Pelletier J. Paradoxical cognitive capacities in dual diagnosis schizophrenia: the quest for explanatory factors. J Dual Diagn (2012) 8(1):35-47. doi:10.1080/15504263.2012.648549.
4. Potvin S. Neuroimaging studies of SA in schizophrenia. Curr Psychiatry Rev (2009) 5(4):250-60. doi:10.2174/157340009789542169.
5. Verdejo-García A, Bechara A, Recknor EC, Pérez-García M. Executive dysfunction in substance dependent individuals during drug use and abstinence: an examination of the behavioral, cognitive and emotional correlates of addiction. J Int Neuropsychol Soc (2006) 12:405-15. doi:10.1017/s1355617706060486.
6. Yücel M, Lubman DI, Solowij N, Brewer WJ. Understanding drug addiction: a neuropsychological perspective. Aust N Z J Psychiatry (2007) 41:957-68. doi:10.1080/00048670701689444.
7. Fein G, Torres J, Price LJ, Sclafani VD. Cognitive performance in long-term abstinent alcoholic individuals. Alcohol Clin Exp Res (2006) 30(9):1538-44. doi:10.1111/j.1530-0277.2006.00185.x.
8. Solowij N. Do cognitive impairments recover following cessation of cannabis use? Life Sci (1995) 56:2119-26. doi:10.1016/0024-3205(95)00197-E.
9. Medina KL, Hanson KL, Schweinsburg AD, Cohen-Zion M, Nagel BJ, Tapert SF. Neuropsychological functioning in adolescent marijuana users: subtle deficits after a month of abstinence. J Int Neuropsychol Soc (2007) 13:807-20. doi:10.1017/S1355617707071032.
10. Pace-Schott EF, Morgan PT, Malison RT, Hart CL, Edgar C, Walker M, et al. Cocaine users differ from normals on cognitive tasks which show poorer performance during drug abstinence. Am J Drug Alcohol Abuse (2008) 34:109-21. doi:10.1080/00952990701764821.
11. Bolla KI, McCann UD, Ricaurte GA. Memory impairment in abstinent MDMA ("ecstasy") users. Neurology (1998) 51(6):1532-7. doi:10.1212/WNL.51.6.1532.
12. Wareing M, Fisk JE, Murphy PN. Working memory deficits in current and previous users of MDMA ("ecstasy"). Br J Psychol (2000) 91:181-8. doi:10.1348/000712600161772.
13. Wareing M, Fisk JE, Murphy PN, Montgomery C. Verbal working memory deficits in current and previous users of MDMA. Hum Psychopharmacol (2004) 19(4):225-34. doi:10.1002/hup.586.
14. Ersche KD, Clark L, London M, Robbins TW, Sahakian BJ. Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology (2006) 31(5):1036-47. doi:10.1038/sj.npp.1300889.
15. Lee J, Park S. Working memory impairments in schizophrenia: a meta-analysis. J Abnorm Psychol (2005) 114(4):599-611. doi:10.1037/0021-843X.114.4.599.
16. Glahn DC, Raglan JD, Abramoff A, Barrett J, Laird AR, Bearden CE, et al. Beyond hypofrontality: a quantitative meta-analysis of functional neuroimaging studies of working memory in schizophrenia. Hum Brain Mapp (2005) 25:60-9. doi:10.1002/hbm.20138.
17. Schweinsburg AD, Nagel BJ, Schweinsburg BC, Park A, Theilmann RJ, Tapert SF. Abstinent adolescent marijuana users show altered fMRI response during spatial working memory. Psychiatry Res (2008) 163(1):40-51. doi:10.1016/j.pscychresns.2007.04.018.
18. Pfefferbaum A, Desmond JE, Galloway C, Menon V, Glover GH, Sullivan EV. Reorganization of frontal systems used by alcoholics for spatial working memory: an fMRI study. Neuroimage (2001) 14:7-20. doi:10.1006/nimg.2001.0785.
19. Desmond JE, Chen SH, DeRosa E, Pryor MR, Pfefferbaum A, Sullivan EV. Increased frontocerebellar activation in alcoholics during verbal working memory: an fMRI study. Neuroimage (2003) 19(4):1510-20. doi:10.1016/S1053-8119(03)00102-2.
20. Tomasi D, Goldstein RZ, Telang F, Maloney T, Alia-Klein N, Caparelli EC, et al. Widespread disruption in brain activation patterns to a working memory task during cocaine abstinence. Brain Res (2007) 1171:83-92. doi:10.1016/j.brainres.2007.06.102.
21. Mueser KT, McGurk SR. Cognitive functioning in schizophrenia and co-occurring substance use disorder: where do we go from here? J Dual Diagn (2012) 8(1):48-9. doi:10.1080/15504263.2012.648435.
22. Thoma P, Daum I. Working memory and multi-tasking in paranoid schizophrenia with and without comorbid substance use disorder. Addiction (2008) 103(5):774-86. doi:10.1111/j.1360-0443.2008.02156.x.
23. Rodriguez-Jimenez R, Bagney A, Martinez-Gras I, Ponce G, Sanchez-Morla EM, Aragües M, et al. Executive function in schizophrenia: influence of substance use disorder history. Schizophr Res (2010) 118:34-40. doi:10.1016/j.schres.2009.09.025.
24. Schnell T, Koethe D, Daumann J, Gouzoulis-Mayfrank E. The role of cannabis in cognitive functioning of patients with schizophrenia. Psychopharmacology (2009) 205(1):45-52. doi:10.1007/s00213-009-1512-9.
25. Yücel M, Bora E, Lubman DI, Solowji N, Brewer WJ, Cotton SM, et al. The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophr Bull (2012) 38(2):316-30. doi:10.1093/schbul/sbq079.
26. Nixon SJ, Hallford G, Tivis RD. Neurocognitive function in alcoholic, schizophrenic, and dually diagnosed patients. Psychiatry Res (1996) 64:35-45. doi:10.1016/0165-1781(96)02911-3.
27. Allen DN, Goldstein G, Forman SD, Keshavan MS, van Kammen DP, Sanders RD. Neurologic examination abnormalities in schizophrenia with and without a history of alcoholism. Neuropsychiatry Neuropsychol Behav Neurol (2000) 13(3):184-7.
28. Peer J, Bennett ME, Bellack AS. Neurocognitive characteristics of individuals with schizophrenia and cocaine dependence: comparison of currently dependent and remitted groups. J Nerv Ment Dis (2009) 197(8):631-4. doi:10.1097/NMD.0b013e3181b08bf4.
29. Serper MR, Bergman A, Copersino ML, Chou JC, Richarme D, Cancro R. Learning and memory impairment in cocaine-dependent and comorbid schizophrenia patients. Psychiatry Res (2000) 93:21-32. doi:10.1016/S0165-1781(99)00122-5.
30. Serper MR, Copersino ML, Richarme D, Vadhan N, Canro R. Neurocognitive functioning in recently abstinent, cocaine-abusing schizophrenia patients. J Subst Abuse (2000) 11(2):205-13. doi:10.1016/S0899-3289(00)00021-3.
31. Jockers-Scherübl MC, Wolf T, Radzei N, Schlattmann P, Rentzsch J, Gómez-Carrillo de Castro A, et al. Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls. Prog Neuropsychopharmacol Biol Psychiatry (2007) 31(5):1054-63. doi:10.1016/j.pnpbp.2007.03.006.
32. Donoghue K, Mazzoncini R, Hart J, Zanelli J, Morgan C, Dazzan P, et al. The differential effect of illicit drug use on cognitive function in first-episode psychosis and healthy controls. Acta Psychiatr Scand (2012) 125(5):400-11. doi:10.1111/j.1600-0447.2011.01803.x.
33. Potvin S, Mancini-Marïe A, Fahim C, Mensour B, Stip E. Processing of social emotion in patients with schizophrenia and substance use disorder: an fMRI study. Soc Neurosci (2007) 2(2):106-16. doi:10.1080/17470910701376787.
34. Mancini-Maïre A, Potvin S, Fahim C, Beauregard M, Mensour B, Stip E. Neural correlates of the affect regulation model in schizophrenia patients with substance use history: a functional magnetic resonance imaging study. J Clin Psychiatry (2006) 67(3):342-50. doi:10.4088/JCP.v67n0302.
35. Rentzsch J, Penzhorn A, Kernbichler K, Plöckl D, Gómez-Carrillo de Castro A, Gallinat J, et al. Differential impact of heavy cannabis use on sensory gating in schizophrenic patients and otherwise healthy controls. Exp Neurol (2007) 205:241-9. doi:10.1016/j.expneurol.2007.02.004.
36. Thoma RJ, Hanlon FM, Miller GA, Huang M, Weisend MP, Sanchez FP, et al. Neuropsychological and sensory gating deficits related to remote alcohol abuse history in schizophrenia. J Int Neuropsychol Soc (2006) 12:34-44. doi:10.1017/S1355617706060097.
37. Schiffer B, Müller BW, Scherbaum N, Forsting M, Wiltfang J, Leygraf N, et al. Impulsivity-related brain volume deficits in schizophrenia-addiction comorbidity. Brain (2010) 133(10):3093-103. doi:10.1093/brain/awq153.
38. Szeszko PR, Robinson DG, Sevy S, Kumra S, Rupp CI, Betensky JD, et al. Anterior cingulate grey-matter deficits and cannabis use in first-episode schizophrenia. Br J Psychiatry (2007) 190:230-6. doi:10.1192/bjp.bp.106.024521.
39. Bangalore SS, Prasad KM, Montrose DM, Gordia D, Diwadkar VA, Keshavan MS. Cannabis use and brain structural alterations in first episode schizophrenia: a region of interest, voxel-based morphometric study. Schizophr Res (2008) 99:1-6. doi:10.1016/j.schres.2007.11.029.
40. Sullivan EV, Deshmukh A, Desmond JE, Mathalon DH, Rosenbloom MJ, Lim KO, et al. Contribution of alcohol abuse to cerebellar volume deficits in men with schizophrenia. Arch Gen Psychiatry (2000) 57(9):894-902. doi:10.1001/archpsyc.57.9.894.
41. Mathalon DH, Pfefferbaum A, Lim K, Rosenbloom MJ, Sullivan EV. Compounded brain volumes deficits in schizophrenia-alcoholism comorbidity. Arch Gen Psychiatry (2003) 60(3):245-52. doi:10.1001/archpsyc.60.3.245.
42. Smith MJ, Wang L, Cronenwett W, Goldman MB, Mamah D, Barch DM, et al. Alcohol use disorders contribute to hippocampal and subcortical shape differences in schizophrenia. Schizophr Res (2011) 131:174-83. doi:10.1016/j.schres.2011.05.014.
43. Scheller-Gilkey G, Lewine RR, Brown FW. Schizophrenia, substance use, and brain morphology. Schizophr Res (1999) 35(2):113-20. doi:10.1016/S0920-9964(98)00096-6.
44. Van Snellenberg JX, Torres IJ, Thornton AE. Functional neuroimaging of working memory schizophrenia: task performance as a moderating variable. Neuropsychology (2006) 20(5):497-510. doi:10.1037/0894-4105.20.5.497.
45. First MB, Spitzer RL, Gibbon M, Williams JB. Structured Clinical Interview for DSM-IV-TR Axis 1 Disorders-Patient Edition (SCID-I/P, 2/2001 Revision). New York, NY: New York Psychiatric Institute, Biometrics Research (2001).
46. Andreasen NC. The Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, IA: University of Iowa (1983).
47. Andreasen NC, Arndt S, Alliger R, Miller D, Flaum M. Symptoms of schizophrenia: methods, meanings, and mechanisms. Arch Gen Psychiatry (1995) 52(5):341-51. doi:10.1001/archpsyc.1995.03950170015003.
48. Jansma JM, Ramsey NF, van der Wee NJ, Kahn RS. Working memory capacity in schizophrenia: a parametric fMRI study. Schizophr Res (2004) 68:159-71. doi:10.1016/S0920-9964(03)00127-0.
49. Barch DM, Csernansky J, Snyder A, Conturo T. Dorsolateral prefrontal cortex dysfunction in schizophrenia: relationship to both working memory and long term memory. Neuroimage (2000) 11(5):S193. doi:10.1016/S1053-8119(00)91126-1.
50. Barch DM, Sheline YI, Csernansky JG, Snyder AZ. Working memory and prefrontal cortex dysfunction: specificity to schizophrenia compared with major depression. Biol Psychiatry (2003) 53(5):376-84. doi:10.1016/S0006-3223(02)01674-8.
51. Braver TS, Barch DM, Kelley WM, Buckner RL, Cohen NJ, Miezen FM, et al. Direct comparison of prefrontal cortex regions engaged by working memory and long-term memory tasks. Neuroimage (2001) 14:48-59. doi:10.1006/nimg.2001.0791.
52. Kelley WM, Miezin FM, McDermott KB, Buckner RL, Raichle ME, Cohen NJ, et al. Hemispheric specialization in human dorsal frontal cortex and medial temporal lobe for verbal and nonverbal memory encoding. Neuron (1998) 20(5):927-36. doi:10.1016/S0896-6273(00)80474-2.
53. Gray JR, Braver TS, Raichle ME. Integration of emotion and cognition in the lateral prefrontal cortex. Proc Natl Acad Sci U S A (2002) 99(6):4115-20. doi:10.1073/pnas.062381899.
54. Gray JR. Emotional modulation of cognitive control: approach-withdrawal states double dissociate spatial from verbal two-back task performance. J Exp Psychol Gen (2001) 130(3):436-52. doi:10.1037/0096-3445.130.3.436.
55. Ekman P, Friesen WV. Unmasking the Face: Guide to Recognizing Emotions from Facial Clues. Englewood Cliffs, NJ: Prentice-Hall (1975).
56. Gur RC, Sara R, Hagendoorn M, Marom O, Hughett P, Macy L, et al. A method for obtaining 3-dimensioanl facial expressions and its standardization for use in neurocognitive studies. J Neurosci Methods (2002) 115(2):137-43. doi:10.1016/S0165-0270(02)00006-7.
57. Talairach J, Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain. New York, NY: Theime (1988).
58. Snyder AZ. Difference image vs ratio image error function forms in PET-PET realignment. In: Myers R, Cunningham V, Bailey D, Jones T, editors. Quantification of Brain Function Using PET. San Diego, CA: Academic Press (1996). p. 131-7.
59. Woods RP, Grafton ST, Holmes CJ, Cherry SR, Mazziotta JC. Automated image registration: I. General methods and intrasubject, intramodality validation. J Comput Assist Tomogr (1998) 22:139-52. doi:10.1097/00004728-199801000-00027.
60. Forman SD, Cohen JD, Fitzgerald M, Eddy WF, Mintun MA, Noll DC. Improved assessment of significant activation in functional magnetic resonance imaging (fMRI): use of a cluster-size threshold. Magn Reson Med (1995) 33(5):636-47. doi:10.1002/mrm.1910330508.
61. McAvoy MP, Ollinger JM, Buckner RL. Cluster size thresholds for assessment of significant activation in fMRI. Neuroimage (2001) 13:S198. doi:10.1016/S1053-8119(01)91541-1.
62. Minzenberg MJ, Laird AR, Thelen S, Carter CS, Glahn DC. Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia. Arch Gen Psychiatry (2009) 66(8):811-22. doi:10.1001/archgenpsychiatry.2009.91.
63. Addington J, Addington D. Substance abuse and cognitive functioning in schizophrenia. J Psychiatry Neurosci (1997) 22(2):99-104.
64. Manning V, Betteridge S, Wanigaratne S, Best D, Strang J, Gossop M. Cognitive impairment in dual diagnosis inpatient with schizophrenia and alcohol use disorders. Schizophr Res (2009) 114:98-104. doi:10.1016/j.schres.2009.05.020.
65. Daumann J, Fimm B, Willmes K, Thron A, Gouzoulis-Mayfrank E. Cerebral activation in abstinent ecstasy (MDMA) users during a working memory task: a functional magnetic resonance imaging (fMRI) study. Brain Res Cogn Brain Res (2003) 16(3):479-87. doi:10.1016/S0926-6410(03)00075-2.
66. Owen AM, McMillan K, Laird AR, Bullmore E. N-back working memory paradigm: a meta-analysis of normative functional neuroimaging studies. Hum Brain Mapp (2005) 25:46-59. doi:10.1002/hbm.20131.
67. Dixon L, Haas G, Weiden PJ, Sweeney J, Frances AJ. Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am J Psychiatry (1991) 148(2):224-30.
68. Carey KB, Carey MP, Simons JS. Correlates of substance use disorder among psychiatric outpatients: focus on cognition, social role functioning and psychiatric status. J Nerv Ment Dis (2003) 191(5):300-8. doi:10.1097/00005053-200304000-00003.
69. Herman M. Neurocognitive functioning and quality of life among dually diagnosed and non-substance abusing schizophrenia inpatients. Int J Ment Health Nurs (2004) 13:282-91. doi:10.1111/j.1440-0979.2004.00346.x.
70. Welsh JA, Buchsbaum DG, Kaplan CB. Quality of life alcoholics and non-alcoholics: does excessive drinking make a difference in the urban setting? Qual Life Res (1993) 2(5):335-40. doi:10.1007/BF00449428.
71. Ventegodt S, Merrick J. Psychoactive drugs and quality of life. ScientificWorldJournal (2003) 3:694-706. doi:10.1100/tsw.2003.57.
72. Blume AW, Marlatt A. The role of executive cognitive functioning in changing substance use: what we know and what we need to know. Ann Behav Med (2009) 37(2):117-25. doi:10.1007/s12160-009-9093-8.
73. Løberg EM, Nygard M, Berle JO, Johnsen E, Kroken RA, Jørgensen HA, et al. An fMRI study of neuronal activation in schizophrenia patients with and without previous cannabis abuse. Front Psychiatry (2012) 3:94. doi:10.3389/fpsyt.2012.00094.
74. Potvin S, Bourque J, Durand M, Lipp O, Lalonde P, Stip E, et al. The neural correlates of mental rotation abilities in cannabis-abusing patients with schizophrenia: an fMRI study. Schizophr Res Treatment (2013) 2013(543848):1-10. doi:10.1155/2013/543842.